Wolfe Research Initiates Coverage On CG Oncology with Peer Perform Rating
CG Oncology Inc CGON
$64.76
▲ +2.31%
(+$1.46)
Open
$64.17
Prev Close
$63.30
Day Range
$63.51 – $65.97
52W Range
$23.65 – $75.50
Market Cap
$5.76B
Beta
0.70
EPS (TTM)
$-2.08
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-01-25 |
| Shares Out. | 88,200,000 |
| Website | cgoncology.com/ ↗ |
| Phone | 13025310855 |
CG Oncology Inc is a publicly traded company under the ticker symbol CGON on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-05-01)
📰 Latest News for CGON
HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $100 Price Target
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
CG Oncology Reports First Results From CORE‑008 Cohort CX Phase 2 Trial
CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears
Truist Securities Reiterates Buy on CG Oncology, Raises Price Target to $82
CG Oncology, Inc. (CGON) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : CG Oncology, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10